Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Males or non-pregnant females at least 6 years of age who had been diagnosed and treated for recurrent, non-infectious uveitis affecting the posterior segment of one or both eyes for at least 1 year prior to the start of the study, and had 'quiet' eyes at surgery~Exclusion Criteria:~* Coexisting medical or ocular conditions that would interfere with the study results

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fluocinolone acetonide 0.59mg (Type: EXPERIMENTAL): Fluocinolone acetonide ocular implant 0.59mg
- Fluocinolone acetonide 2.1mg (Type: EXPERIMENTAL): Fluocinolone acetonide ocular implant 2.1mg
- No intervention (Type: NO_INTERVENTION): Fellow eye

Based on this trial design, predict the completion outcome and termination type (if applicable).